【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 11
2 Introduction 12
2.1 Electrophysiology Devices Overview 12
3 Products under Development 14
3.1 Electrophysiology Devices – Pipeline Products by Stage of Development 14
3.2 Electrophysiology Devices – Pipeline Products by Segment 15
3.3 Electrophysiology Devices – Pipeline Products by Territory 16
3.4 Electrophysiology Devices – Pipeline Products by Regulatory Path 18
3.5 Electrophysiology Devices – Pipeline Products by Estimated Approval Date 19
3.6 Electrophysiology Devices – Ongoing Clinical Trials 20
4 Electrophysiology Devices – Pipeline Products under Development by Companies 21
4.1 Electrophysiology Devices Companies – Pipeline Products by Stage of Development 21
4.2 Electrophysiology Devices – Pipeline Products by Stage of Development 24
5 Electrophysiology Devices Companies and Product Overview 27
5.1 AblaCor Medical Corporation Company Overview 27
5.1.1 AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 27
5.2 Acutus Medical, Inc. Company Overview 28
5.2.1 Acutus Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
5.3 Advanced Cardiac Therapeutics, Inc. Company Overview 30
5.3.1 Advanced Cardiac Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.4 AFfix Medical Ltd. Company Overview 31
5.4.1 AFfix Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31
5.5 Apama Medical, Inc. Company Overview 34
5.5.1 Apama Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
5.6 AtriCure, Inc. Company Overview 35
5.6.1 AtriCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.7 Baylor College of Medicine Company Overview 41
5.7.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 41
5.8 Biosense Webster, Inc. Company Overview 43
5.8.1 Biosense Webster, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
5.9 BioSig Technologies, Inc. Company Overview 47
5.9.1 BioSig Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
5.10 BioTex, Inc. Company Overview 48
5.10.1 BioTex, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.11 Boston Scientific Corporation Company Overview 50
5.11.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 50
5.12 C. R. Bard, Inc. Company Overview 65
5.12.1 C. R. Bard, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
5.13 Cardima, Inc. (Inactive) Company Overview 69
5.13.1 Cardima, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 69
5.14 CardioFocus, Inc. Company Overview 72
5.14.1 CardioFocus, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
5.15 CardioNova Ltd. Company Overview 76
5.15.1 CardioNova Ltd. Pipeline Products & Ongoing Clinical Trials Overview 76
5.16 CathEffects LLC Company Overview 77
5.16.1 CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 77
5.17 CathRx Ltd Company Overview 78
5.17.1 CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 78
5.18 Cordis Corporation Company Overview 82
5.18.1 Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview 82
5.19 CoRepair, Inc Company Overview 84
5.19.1 CoRepair, Inc Pipeline Products & Ongoing Clinical Trials Overview 84
5.20 CyberHeart Incorporated Company Overview 85
5.20.1 CyberHeart Incorporated Pipeline Products & Ongoing Clinical Trials Overview 85
5.21 Epicardial Technologies Inc Company Overview 87
5.21.1 Epicardial Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 87
5.22 FocusStart Orthosensors Company Overview 88
5.22.1 FocusStart Orthosensors Pipeline Products & Ongoing Clinical Trials Overview 88
5.23 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Company Overview 89
5.23.1 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview 89
5.24 Hansen Medical, Inc. Company Overview 90
5.24.1 Hansen Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90
5.25 Imricor Medical Systems, Inc. Company Overview 97
5.25.1 Imricor Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 97
5.26 Interventional Imaging, Inc. Company Overview 102
5.26.1 Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 102
5.27 Iowa Approach Inc. Company Overview 103
5.27.1 Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview 103
5.28 Maestro Heart SA Company Overview 106
5.28.1 Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview 106
5.29 Mayo Clinic. Company Overview 107
5.29.1 Mayo Clinic. Pipeline Products & Ongoing Clinical Trials Overview 107
5.30 MC10, Inc. Company Overview 108
5.30.1 MC10, Inc. Pipeline Products & Ongoing Clinical Trials Overview 108
5.31 Medicalgorithmics S.A. Company Overview 110
5.31.1 Medicalgorithmics S.A. Pipeline Products & Ongoing Clinical Trials Overview 110
5.32 Medispec LTD Company Overview 111
5.32.1 Medispec LTD Pipeline Products & Ongoing Clinical Trials Overview 111
5.33 Medlumics S.L. Company Overview 113
5.33.1 Medlumics S.L. Pipeline Products & Ongoing Clinical Trials Overview 113
5.34 Medtronic plc Company Overview 115
5.34.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 115
5.35 MedWaves Incorporated Company Overview 120
5.35.1 MedWaves Incorporated Pipeline Products & Ongoing Clinical Trials Overview 120
5.36 MicroPort Scientific Corporation Company Overview 122
5.36.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 122
5.37 MRI Interventions, Inc Company Overview 125
5.37.1 MRI Interventions, Inc Pipeline Products & Ongoing Clinical Trials Overview 125
5.38 nContact, Inc. Company Overview 127
5.38.1 nContact, Inc. Pipeline Products & Ongoing Clinical Trials Overview 127
5.39 North Carolina State University Company Overview 131
5.39.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 131
5.40 Northwestern University Company Overview 132
5.40.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 132
5.41 Philips Healthcare Company Overview 134
5.41.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 134
5.42 SCR, Inc. Company Overview 136
5.42.1 SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 136
5.43 St. Jude Medical, Inc. Company Overview 137
5.43.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 137
5.44 Stereotaxis, Inc. Company Overview 144
5.44.1 Stereotaxis, Inc. Pipeline Products & Ongoing Clinical Trials Overview 144
5.45 Strategic Polymer Sciences, Inc Company Overview 147
5.45.1 Strategic Polymer Sciences, Inc Pipeline Products & Ongoing Clinical Trials Overview 147
5.46 The Cleveland Clinic Foundation Company Overview 148
5.46.1 The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview 148
5.47 University of Rochester Company Overview 150
5.47.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 150
5.48 University of Texas Medical Branch at Galveston Company Overview 152
5.48.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 152
5.49 Vimecon GmbH Company Overview 154
5.49.1 Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview 154
5.50 Vivonics, Inc. Company Overview 156
5.50.1 Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 156
5.51 Voyage Medical Company Overview 159
5.51.1 Voyage Medical Pipeline Products & Ongoing Clinical Trials Overview 159
6 Electrophysiology Devices- Recent Developments 161
7 Appendix 223
7.1 Methodology 223
7.2 About GlobalData 225
7.3 Contact Us 226
7.4 Disclaimer 226
【レポート販売概要】
■ タイトル：世界の電気生理学装置開発動向：医療機器パイプライン分析2015■ 英文：Electrophysiology Devices - Medical Devices Pipeline Assessment, 2015
■ 発行日：2016年1月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0131EPD
■ 調査対象地域：グローバル
- 医薬品グレードシリカゲルの世界市場分析：用途別（乾燥剤、薬物キャリア[難溶性薬物、液体薬物]、吸着剤、流動促進剤）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、中南米）、セグメント予測The global pharmaceutical grade silica gel market is projected to reach a market size of USD 71.05 million by 2025, according to a new report by Grand View Research, Inc. The pharmaceutical grade silica gel market is expected to witness significant growth over the forecast period owing to the increasing demand for excipients. Pharmaceutical grade silica gel is used in a various applications includ …
- 世界のDCモーター ドライブ市場（2014-2018）About DC Drives A drive is an adjustable speed device that regulates the speed and direction of motors. The adjustment is made by varying the current flow through the motor. Drives are classified into two broad categories based on the type of current: AC drives and DC drives. AC drives are used to control AC electric motors, while DC drives are used for DC electric motors. Drives are widely used i …
- トランスクリプトミクスの世界市場：装置、消耗品、技術About Transcriptomics Transcriptomics involves the collection and analysis of transcriptomes of different types of cells or tissues present in an organism. The transcriptome characterizes the set of all RNA molecules, which is a part of the genetic code. The difference in genetic expression symbolizes the wide-ranging biochemical and physical differences present among various cells and tissues tha …
- 慢性脊髄損傷：グローバル臨床試験レビュー（2014年上半期）Chronic Spinal Cord Injury Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Chronic Spinal Cord Injury Global Clinical Trials Review, H1, 2014" provides data on the Chronic Spinal Cord Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Spinal Cord Injury. It includes an overview of the t …
- 紫外線LED（UV LED）の世界市場：UVA、UVB、UVCThe UV LED is a growing technology with new developments and applications leading the use of different wavelength for variety of applications. This market is growing as the interest of major players to invest in UV LED is increasing despite the high cost of UV LED. This technology is used in various segments such as industrial, security, sterilization and medical & scientific along with various ap …
- 農薬と殺虫剤市場：タンザニアThis report is a comprehensive research of agrochemicals and pesticides market in Tanzania. The report starts with giving brief country profile for Tanzania, including general information and main economic indicators. Further, the report provides in-depth analyses agrochemicals and pesticides market in the country. It identifies key market players, including major producers, wholesalers and distri …
- レーザ加工機の世界市場：切断/穴あけ/マーキング加工、固体式/気体式/ファイバレーザ加工機などDifferent laser technologies comprising gas, solid, and fiber are used for laser processing techniques, which includes cutting, welding, drilling, marking, and engraving. The laser processing market is expected to witness a high demand during the forecast period, owing to the wide applications of laser technology. The value of the laser processing market is set to grow at CAGR of 6.18%, from $ 11. …
- 生鮮食品包装のヨーロッパ市場：果物、野菜、サラダThe Europe fresh food packaging market size was valued at $3,718.2 million in 2017 and is expected to reach $4,890.6 million by 2026, registering a CAGR of 3.1% from 2019 to 2026. Food packaging helps in retardation of product deterioration, retainment of the beneficial effects of processing, helps in extension of shelf-life, and increasing and maintaining the quality and safety of food. European …
- プリンテッドエレクトロニクスの世界市場2017-2021About Printed ElectronicsPrinted electronics is a set of printing methods, which is used to create electrical devices on different substrates such as plastic, ceramic, and textiles Technavio’s analysts forecast the global printed electronics market to grow at a CAGR of 8.26% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects of the …
- 西ヨーロッパのスマートホームM2M通信市場2016-2020About the Smart Home M2M Market in Western Europe Western Europe is known to be one of the most technologically advanced economies in the world and an early adopter of new technologies across industries. Smart home technology is expected to witness exponential growth and adoption in the coming years in Western Europe. The market promises huge opportunities for the connected M2M home appliance play …
- 世界のスマートシティ市場Summary 'Smart Cities: A Challenging but Attractive Opportunity for Network Operators,' a Research Report by Pyramid Research, analyzes the smart city proposition for network operators worldwide and how they are addressing the opportunity. The report discusses the urbanization trends worldwide and provides an in-depth analysis of elements of smart city services, the stakeholders in smart city proj …
- 4G Handsets: Evaluating the Impact of LTE, Applications, and Anticipated UsageThe Long Term Evolution (LTE) standard was introduced in 3GPP (3rd Generation Partnership Project) Release 8 as an evolutionary step representing the fourth generation (4G) of cellular communications. It provides an enhanced user experience for broadband wireless networks and will usher in a plethora of new bandwidth dependent applications. This research analyzes current mobile handsets market as …
- 世界の通信産業におけるマネージド・サービス市場動向（2012-2016）TechNavio's analysts forecast the Global Managed Services market in the Telecom industry to grow at a CAGR of 17.78 percent over the period 2012-2016. One of the key factors contributing to this market growth is the contribution of managed services to a reduction in service providers' overall expenses. The Global Managed Services market in the Telecom industry has also been witnessing the increasi …
- 肥厚性心筋症（Hypertropic Cardiomyopathy）：治療薬のグローバル治験動向（2014年下半期）Hypertropic Cardiomyopathy Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Hypertropic Cardiomyopathy Global Clinical Trials Review, H2, 2014" provides data on the Hypertropic Cardiomyopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypertropic Cardiomyopathy. It includes an overview of the t …
- 3G<E上のモバイルセキュリティー及びプライバシー：戦略、ソリューション、予測（Mobile Security and Privacy in 3G & LTE: Strategies, Solutions and Market Forecast Analysis 2012-2017）This market has been initially driven by business concerns about protection of corporate assets and information. Mobile threats are becoming increasingly prolific as the mobile platform continues to gain popularity through the adoption of smart devices. As end-users and businesses come to rely on smartphones and tablets in their personal and business activities, they store valuable information tha …
